Nipple Aspirate Test: Safety Communication
MedSun: Newsletter #91, January 2014

FDA MedWatch Safety Alert

The FDA is alerting the public, including women and health care providers, that a nipple aspirate test is not a replacement for mammography, other breast imaging tests, or breast biopsy, and should not be used by itself to screen for or diagnose breast cancer. The FDA is not aware of any valid scientific data to show that a nipple aspirate test by itself is an effective screening tool for any medical condition including the early detection of breast cancer or other breast disease.

Additional Information:

Nipple Aspirate Test: Safety Communication. FDA MedWatch Safety Alert. December 12, 2013.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm378489.htm


MedSun Newsletters are available at www.fda.gov/cdrh/medsun